Navigation Links
Exome sequencing: Defining hereditary deafness
Date:9/14/2011

Precise diagnosis of disease and developmental syndromes often depends on understanding the genetics underlying them. Most cases of early onset hearing loss are genetic in origin but there are many different forms. Heretofore, it has been difficult to identify the gene responsible for the hearing loss of each affected child, because the critical mutations differ among countries and populations. New research published in BioMed Central's open access journal Genome Biology has identified six critical mutations in Israeli Jewish and Palestinian Arab families. Mutations in one gene, TMC1, was found in 38% of children with genetic hearing loss in the Moroccan Jewish population.

Using targeted DNA capture and massively parallel sequencing (MPS), researchers screened 246 deafness-related genes in 11 unrelated individuals, all of whom were diagnosed with deafness that ran in their families. Once a mutation was found, the mutation was then tested in an extended series of families with hearing loss, and DNA sequences compared to those of people with normal hearing. Mutations were found in five genes -- CDH23, MYO15A, TECTA, TMC1, and WFS1. A mutation not previously observed in any family, TMC1 p.S647P, was found in 34% of people with hearing loss who are of Moroccan Jewish ancestry. This mutation was not found in deaf individuals of other ancestries. Each new mutation was specific to families of one ancestry, indeed most were private, in only to one family.

Prof Karen Avraham from Tel Aviv University explained, "Our two-tier approach allowed us to scan exons of genes, thought to be involved in hereditary deafness, and their flanking sequences. This meant that we were able to quickly target specific genes and find multiple mutations responsible for hearing loss." Prof Moein Kanaan of Bethlehem University added, "Use of genomic analysis in early clinical diagnosis of hearing loss will enable us to predict how each child's hearing loss will progress. It will also show us where to look for the biological mechanisms involved in hearing loss."

This article is part of a special Genome Biology issue focusing on exome sequencing. Sequencing is still expensive and time consuming. However exome sequencing, where only the exons of a subject are sequenced, by first capturing the DNA with relevant probes, significantly reduces the costs compared to whole genome sequencing. It allows researchers to zone in on specific sites, reducing the amount of code they need to cover, to find causative mutations.


'/>"/>

Contact: Guy Melzack
guy.melzack@biomedcentral.com
44-203-192-2363
BioMed Central
Source:Eurekalert

Related biology news :

1. NIH researchers complete whole-exome sequencing of skin cancer
2. Knome Awards Human Exome Sequencing and Analysis to Biomedical Researchers
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. NIH-funded researchers sequence exomes of 12 people
5. First step toward electronic DNA sequencing: Translocation through graphene nanopores
6. Redefining what it means to be a prion
7. Scientists make strides toward defining genetic signature of Alzheimers disease
8. Study offers new clues about hereditary spastic paraplegia
9. First diagnostic test for hereditary childrens disease
10. DNA discovery opens new door to develop tools, therapies for hereditary cancers
11. Researchers identify gene linked to hereditary incontinence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: